MedPath

Study on Opioid-free Anesthesia Protocol With S-ketamine and Propofol

Not Applicable
Conditions
S-ketamine
Opioid Use, Unspecified
Interventions
Registration Number
NCT05242081
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

The purpose of this study was to observe the effects of opioid-free anesthesia with S-ketamine on postoperative analgesia and perioperative hemodynamics in short surgical operations, and to explore the effects of S-ketamine on postoperative awakening time and extubation time, nausea and vomiting, hypoxemia, and delirium.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
980
Inclusion Criteria
  1. Aged from 18 years to 65 years
  2. American society of anesthesiologists physical status classification I-II
  3. Patients scheduled for elective laparoscopic cholecystectomy
  4. Willing to sign informed consent
Exclusion Criteria
  1. Allergic to narcotic drugs;
  2. Surgical history within the past 1 month;
  3. patients with neurological diseases or mental disorders;
  4. Unable to understand numerical rating Scale (NRS);
  5. patients with untreated or poorly controlled hypertension (arterial hypertension, resting systolic/diastolic blood pressure over 180/100mmHg);
  6. patients with untreated or undertreated hyperthyroidism;
  7. Patients with unstable angina pectoris or myocardial infarction in the past 6 months;
  8. When intraocular pressure is high (glaucoma) and penetrating ocular trauma, intraocular pressure cannot rise.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
S-ketamineS-ketamine-
SufentanilSufentanil-
Primary Outcome Measures
NameTimeMethod
The probability of numerical rating scale (NRS) score being less than or equal to 3 when leaving the Postanesthesia Care Unit (PACU)1 day of the surgery

The probability of numerical rating scale (NRS) score being less than or equal to 3 when leaving the Postanesthesia Care Unit (PACU)

Secondary Outcome Measures
NameTimeMethod
Incidence of hypoxemia48 hours after the surgery
The duration of surgeryFrom the date of the beginning of surgery until the date of the end of surgery, assessed up to 2 days
Time to removal of tracheal intubationFrom the end of anesthesia until the time of removal of tracheal intubation, assessed up to 2 days
Incidence of postoperative nausea and vomiting48 hours after the surgery
Incidence of postoperative delirium48 hours after the surgery
numerical rating scale (NRS) pain score24 hours and 48 hours after the surgery
The area under the curve (AUC) of mean arterial pressure (MAP) within 10 minutes after induction is lower than the baseline mean arterial pressure (MAP 3 minutes before induction).From the date of the beginning of anesthesia until the date of the end of anesthesia, assessed up to 2 days

The area under the curve (AUC) of mean arterial pressure (MAP) within 10 minutes after induction is lower than the baseline mean arterial pressure (MAP 3 minutes before induction).

herat rate and blood pressure during the surgery every 5 minutesFrom the date of the beginning of anesthesia until the date of the end of anesthesia, assessed up to 2 days
Time until awakeFrom the end of anesthesia until awake, assessed up to 2 days
Total dosage of anesthesia drugFrom the date of the beginning of anesthesia until the date of the end of anesthesia, assessed up to 2 days
Total dosage of vasoactive agentsFrom the date of the beginning of anesthesia until the date of the end of anesthesia, assessed up to 2 days
Postoperative first analgesia demandFrom the end of anesthesia until the date of first demand of analgesia drugs, assessed up to 1 week

The first time that the patient ask for analgesia

Postoperative hospital stayFrom the date of the surgery until the date being discharged from hospital, up to 1 month

Trial Locations

Locations (1)

The First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath